Boston, MA -- (SBWIRE) -- 06/14/2013 -- EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast to 2022

Summary

Dermatophytic onychomycosis (DO) is an infection of the nail fold or nail plate with dermatophytes, a type of fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton flocossom (Sterry et al., 2006). DO begins as a white/yellow spot under the tip of the nail. As the infection spreads deeper, it causes further discoloration and thickening of the nail, resulting in nail disfigurement and pain/discomfort.

The high worldwide prevalence of DO is primarily due to changes in factors relating to lifestyle, customs, and culture. The incidence and prevalence of DO in the EU was stable over a period of 30 years between the 1960s and 1990s due to a decline in industries such as coal mining, representing decreased use of industrial baths, while simultaneously there has been an increase in prevalence resulting from the use of communal recreational facilities, which led to a constant incidence of DO (Roberts, 1992; Seebacher et al., 2008). In Japan, the traditional Japanese practice of walking barefoot in the house, which facilitates the spread of the infection to family members, is the primary reason for the especially high prevalence and intensity of toenail fungal disease in Japan (Nishimoto, 2006; Watanabe et al., 2010).

View Full Report Details and Table of Contents

Scope

- The Dermatophytic Onychomycosis (DO) EpiCast Report provides an overview of the risk factors and global trends of DO in the seven major markets (US, France, Germany, Italy, Spain, UK, and Japan).
- It also includes a 10-year epidemiology forecast of the prevalent cases of DO, segmented by sex, and age (15-29 years, 30-49 years, 50-69 years, and >70 years) in these markets.

Reasons to Get This Report

- Develop business strategies by understanding the trends shaping and driving the global DO market.
- Quantify patient populations in the global DO market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for DO therapeutics in each of the markets covered.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Dermatophytic Onychomycosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- EpiCast Report: Pediatric Respiratory Syncytial Virus Infection and Prophylactic Populations in the US - Epidemiology Forecast to 2022
- EpiCast Report: Psoriasis - Epidemiology Forecast to 2022
- EpiCast Report: Postmenopausal Vaginal Atrophy - Epidemiology Forecast to 2022
- EpiCast Report: Dry Eye Syndrome - Epidemiology Forecast to 2022
- EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022
- EpiCast Report: Human Immunodeficiency Virus - Epidemiology Forecast to 2022
- EpiCast Report: Dyslipidemia Epidemiology Forecast to 2022
- EpiCast Report: Epilepsy - Epidemiology Forecast to 2022
- EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2022